ELANE p.Pro229Ala
c.685C>G · VCV4783766
Computational evidence
| Protein change | ||
| AlphaMissense | 0.4938 | ambiguous |
|---|---|---|
| REVEL | 0.511 | indeterminate |
| SaProt | LLR -8.54 | tolerated |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.3 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 1.04 | unconstrained · MANE · 3,171 bp · p 0.52 · regional, not allelic |
| Overall | ||
| CADD | 21.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ELANE
- Protein
- p.Pro229Ala
- Coding
- c.685C>G
- MANE Select
- NM_001972
- Type
- single nucleotide variant
- Location
- chr19:856045 (GRCh38)
- Gene constraint
- LOEUF 1.245 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 88.42 · 38 PDB
- Residue 229
- the peptidase s1 domain
Disease context
neutropenia, severe congenital, 1, autosomal dominant — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: cyclic neutropenia
For Autosomal dominant severe congenital neutropenia (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Infancy, Neonatal
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- ELANE p.Pro229= Likely benign ★ same residue
- ELANE c.597+1G>A Pathogenic ★★ same condition
- ELANE c.597+1G>C Pathogenic ★★ same condition
- ELANE c.597+1G>T Pathogenic ★★ same condition
- ELANE c.597+5G>A Pathogenic/Likely pathogenic ★★ same condition
- ELANE p.Ala57Thr Pathogenic/Likely pathogenic ★★ same condition
- ELANE p.Ala61Val Pathogenic/Likely pathogenic ★★ ⚠ same condition
- ELANE p.Arg103Pro Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/elane-p-pro229ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown